MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0021170
Infexn Laboratories Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹25.35 Cr
▲ 8% YoY
Net profit · FY 2024
₹2.5 Lakh
Net margin 0.1%
EBITDA · FY 2024
₹1.64 Cr
EBITDA margin 6.5%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹72 Lakh
No open charges
Company age
13 yrs
Est. 2013
Employees · EPFO
111
Provident fund records
About Infexn Laboratories Private Limited
Data last updated:
Infexn Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 28 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2013PTC241460. Its GSTIN is 27AADCI2200G1Z5 (Maharashtra).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sachin Baliram Bhole and Anil Nanu Nair.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 'C' 1003 Station Plaza Bhandup (West), Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.35 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.5 Lakh (net margin 0.1%) and EBITDA of ₹1.64 Cr (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 38% over five years.
The company has about 111 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: InfeXn. As per MCA filings, the company has satisfied charges of ₹72 Lakh on record. Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in January 2020. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.) are compared by revenue, 3 larger; the largest is Centralab Healthcare Services Private Limited with revenue of ₹25.51 Cr. The company has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 112 overdue payments to 14 micro and small suppliers.
Infexn Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0021170). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website infexn.in.
Company details
CIN U74999MH2013PTC241460
Registration Number 241460
Incorporation Date 28 March 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0021170
Recognitions & Rankings of Infexn Laboratories
Contact details
Infexn Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is infexn.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address'C' 1003 Station Plaza Bhandup (West), Mumbai, Maharashtra, India – 400078
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Infexn Laboratories Private Limited, buy the company report.
Comprehensive company report
Infexn Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Infexn Laboratories is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Infexn Laboratories Private Limited, buy the company report.
Financials of Infexn Laboratories Private Limited
FY 2025 filings availableInfexn Laboratories Private Limited reported revenue of ₹25.35 Cr (up 8% YoY) for FY 2024.
Revenue · FY 2024
₹25.35 Cr ▲ 8%
Net profit · FY 2024
₹2.5 Lakh margin 0.1%
EBITDA · FY 2024
₹1.64 Cr margin 6.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 29%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 132%
3 years · compounded
▼ 65%
5 years · compounded
▲ 50%
Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 8% growth in the latest year. EBITDA rose 132% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Infexn Laboratories Private Limited, buy the company report.
Board of directors of Infexn Laboratories Private Limited
Infexn Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Baliram Bhole | Director | 28 Mar 2013 | 13 Years 7 Months | Current |
| Anil Nanu Nair Also directs: Labguru Healthcare Private Limited | Director | 28 Mar 2013 | 13 Years 7 Months | Current |
| Sonal Rajesh Bangde | Director | 28 Mar 2013 | 13 Years 7 Months | Current |
Peer comparison
Infexn Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Centralab Healthcare Services Private Limited | ₹25.51 Cr (FY 2025) | 45.0% | Mumbai, Maharashtra, India | |||
| Dr. Patel Metropolis Healthcare Private Limited | ₹25.47 Cr (FY 2021) | 68.0% | Mumbai, Maharashtra, India | |||
| Bidyut Prava Healthcare Private Limited | ₹25.36 Cr (FY 2025) | 18.0% | Cuttack, Odisha, India | |||
| Infexn Laboratories Private Limitedthis company | ₹25.35 Cr (FY 2024) | ₹2.5 Lakh | 0.1% | 8.0% | 111 | Mumbai, Maharashtra, India |
To see the full peer comparison of Infexn Laboratories Private Limited, buy the company report.
Auditor
Infexn Laboratories Private Limited is audited by SHS and & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHS and & Co | FY 2023 | 141617W |
Shareholding
The shareholding of Infexn Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Infexn Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹72 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jun 2018 | 100187061 | Others | ₹35 Lakh | Satisfied | |
| 21 Mar 2018 | 100167925 | Others | ₹22 Lakh | Satisfied | |
| 08 Mar 2017 | 100086015 | Others | ₹15 Lakh | Satisfied |
To see the full charge records of Infexn Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Infexn Laboratories Private Limited has 4 deals on record (4 secondary share transfers); the latest was in January 2020.
Total deals
4
Secondary share transfers
4
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Jan 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Labguru Healthcare Private Limited |
| May 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Labguru Healthcare Private Limited , an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Infexn Laboratories Private Limited has 4 court cases on record: 4 filed by Infexn Laboratories. 3 cases are pending and 1 is disposed.
Total cases
4
Filed by the company
4
Pending
3
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 3 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Pending |
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Pending |
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against an individual | Pending |
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against City Hospital Kulkarni Proprietor | Disposed |
To see the full case history of Infexn Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Infexn Laboratories Private Limited has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 112 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Solution One | |||
| Omkar Traders | |||
| Adt India Private Limited |
To see the full MSME payment records of Infexn Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Infexn Laboratories Private Limited has a workforce of 111 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
111
Active EPFO establishments
1
Employee growth
-10.5%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 111 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Infexn Laboratories Private Limited, buy the company report.
GST
Infexn Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCI2200G1Z5 | Maharashtra | Active | 27 Apr 2024 |
To see the full GST registrations and return filing status of Infexn Laboratories Private Limited, buy the company report.
Recent activity
Infexn Laboratories Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Harish Balakrishnan Nair ceased to be Director on 01 May 2017.
AGM
Infexn Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Infexn Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 20 Jun 2018 via Charge ID 100187061 with Others was fully satisfied on 01 Oct 2022.
Charges
A charge registered on 21 Mar 2018 via Charge ID 100167925 with Others was fully satisfied on 22 Jul 2020.
Charges
A charge registered on 08 Mar 2017 via Charge ID 100086015 with Others was fully satisfied on 22 Jul 2020.
Charges
A charge with Others amounted to Rs. 35.00 Lakh with Charge ID 100187061 was registered on 20 Jun 2018.
Charges
A charge with Others amounted to Rs. 22.00 Lakh with Charge ID 100167925 was registered on 21 Mar 2018.
Ceased
Harish Balakrishnan Nair ceased to be Director.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100086015 was registered on 08 Mar 2017.
Appointed
Anil Nanu Nair was appointed as Director.
Appointed
Sachin Baliram Bhole was appointed as Director.
Appointed
Sonal Rajesh Bangde was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Infexn Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 28 March 2013 (13+ years old) and is registered under CIN U74999MH2013PTC241460.
Infexn Laboratories has 3 current directors:
- Sachin Baliram Bhole - Director
- Anil Nanu Nair - Director
- Sonal Rajesh Bangde - Director
The latest financial statements of Infexn Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Infexn Laboratories is 27AADCI2200G1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Infexn Laboratories is U74999MH2013PTC241460. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infexn Laboratories has 4 court cases on record: 4 filed by the company. 3 are pending.
Infexn Laboratories was incorporated on 28 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Infexn Laboratories has 4 deals on record (4 secondary share transfers); the latest was in January 2020.
The peers of Infexn Laboratories by revenue are Centralab Healthcare Services Private Limited, Dr. Patel Metropolis Healthcare Private Limited, Bidyut Prava Healthcare Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Harish Balakrishnan Nair ceased to be Director on 01 May 2017. Anil Nanu Nair was appointed as Director on 28 Mar 2013. Sachin Baliram Bhole was appointed as Director on 28 Mar 2013. Infexn Laboratories has 4 board changes on record in total.
Yes, Infexn Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0021170).
Infexn Laboratories has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 112 overdue payments to 14 micro and small suppliers. The latest return was filed on 16 Nov 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages